About Marker Therapeutics
Investors/Media
SEC Filings
Filing date Form Description View
POS AM

Post-effective amendment to an S-Type filing

EX-101.INS - View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
SC 13D/A

An amendment to a SC 13D filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.INS - View HTML

Data provided by Kaleidoscope.